This inventor holds 2 USPTO granted patents. Top assignee: Agency for Science, Technology and Research. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Vanessa Mei Yee Ding: Innovator in Monoclonal Antibodies
Introduction
Vanessa Mei Yee Ding is a prominent inventor based in Singapore, known for her contributions to the field of biotechnology. She has been awarded 2 patents for her innovative work, particularly in the development of monoclonal antibodies.
Latest Patents
Her latest patents focus on anti-annexin A2 monoclonal antibodies. The first patent describes an antigen-binding protein that includes specific heavy and light chain variable domains with unique amino acid sequences. This invention also encompasses compositions and methods for using the antigen-binding protein, as well as kits that include the protein. The second patent similarly details an antigen-binding protein against annexin A2, highlighting its potential applications in cancer treatment and detection.
Career Highlights
Vanessa is affiliated with the Agency for Science, Technology and Research, where she continues to advance her research in antibody development. Her work is pivotal in the ongoing efforts to create targeted therapies for cancer.
Collaborations
She collaborates with notable colleagues, including Simeon Cua and Andre Boon Hwa Choo, contributing to a dynamic research environment.
Conclusion
Vanessa Mei Yee Ding's innovative work in monoclonal antibodies positions her as a key figure in biotechnology, with significant implications for cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile